Kurt C. Demel

Kurt C. Demel

Internal Medicine
411 Stageline Rd
Hudson, WI 54016

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: Phase 1/2 trial results.

HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: Phase 1/2 trial results.

Journal: Cell reports. Medicine
Published: July 17, 2025
Showing 1-1 of 1

Last Updated: 09/26/2026